SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-004946
Filing Date
2024-01-19
Accepted
2024-01-19 17:29:17
Documents
15
Period of Report
2024-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191856-8k_allarity.htm   iXBRL 8-K 63365
2 FIFTH CERTIFICATE OF AMENDMENT (SERIES A PREFERRED STOCK) ea191856ex3-1_allarity.htm EX-3.1 9587
3 SENIOR CONVERTIBLE NOTE ea191856ex4-1_allarity.htm EX-4.1 136464
4 SECURITIES PURCHASE AGREEMENT, DATED AS OF JANUARY 18, 2024, BY AND BETWEEN THE ea191856ex10-1_allarity.htm EX-10.1 277678
  Complete submission text file 0001213900-24-004946.txt   775121

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE allr-20240118.xsd EX-101.SCH 3015
6 XBRL LABEL FILE allr-20240118_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE allr-20240118_pre.xml EX-101.PRE 22359
9 EXTRACTED XBRL INSTANCE DOCUMENT ea191856-8k_allarity_htm.xml XML 3515
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 24546539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)